Tether, a leading stablecoin issuer known for its USDT currency, has made a significant move in the biotechnology sector with a $200 million investment in Blackrock Neurotech.
This strategic investment through the newly established venture division of Tether, Tether Evo, marks an important step in diversifying its interests beyond cryptocurrency and towards cutting-edge medical technologies.
Tether enters the Biotechnology Sector with a $200 Million Investment in Blackrock Neurotech
Tether’s investment in Blackrock Neurotech is not just a financial initiative; it is a substantial commitment to the field of brain-computer interface (BCI) technology.
With this move, Tether has become the main shareholder of Blackrock Neurotech, signaling strong support for the biotech’s innovative approach in the field of medical science.
The investment is intended to finance the commercialization and expansion of Blackrock’s cutting-edge medical solutions, focused on improving t
We współpracy z: https://en.cryptonomist.ch/2024/04/29/tether-invests-200-million-in-blackrock-neurotech/
